Delivery Order SPE2DB22D3016-SPE2DB24FBBU1
Award Date
7/22/24
Potential Completion Date
8/12/24
Potential Value
$9.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $10,567.60 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LYNPARZA 150 MG TABLET UU 120S, a pharmaceutical product, with an ultimate completion date of March 3, 2025. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LYNPARZA 100 MG TABLET UU 120S. The contract has a firm fixed price of $21,039.24 and a completion date of June 4, 2025. AmerisourceBergen Drug Corp is the prime contractor, and the contract is not set aside. The company holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a...
This is a $10,567.60 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LYNPARZA 150 MG TABLET UU 120S, a pharmaceutical product, with a period of performance through July 14, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide LYNPARZA 100 MG TABLET UU 120S. The contract has a potential value of $39,357.76 and a completion date of February 22, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 and...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 150 mg Lynparza tablets. The contract has a ceiling value of $20,998.68 and a performance period ending on June 16, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle...
This is a $10,499.34 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of LYNPARZA 150 MG TABLET UU 60S. The award has an ultimate completion date of July 1, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which serves as a comprehensive global...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LYNPARZA 100 mg tablets. The contract has a ceiling value of $31,558.86 and a period of performance through July 3, 2025. It is a firm-fixed-price contract, without a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $39,357.76 firm fixed price delivery order is for the pharmaceutical product Lynparza 100 mg tablets. The contract has an ultimate completion date of June 12, 2024. Amerisourcebergen, a major supplier of pharmaceuticals and medical supplies to the federal government, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,567.60, is for the delivery of Lynparza 150 mg tablets. The contract is a firm fixed-price delivery order, with a period of performance through March 7, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 100 mg Lynparza tablets. The $9,839.44 firm fixed price contract has a completion date of December 3, 2024. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...